Written question asked by Jim Shannon (Democratic Unionist Party) on Monday, 16 November 2015, in the House of Commons. It was due for an answer on Wednesday, 18 November 2015. It was answered by George Freeman (Conservative) on Monday, 23 November 2015 on behalf of the Department of Health.
Muscular Dystrophy: Drugs
- Question
-
To ask the Secretary of State for Health, if he will make Translarna available on the NHS to treat Duchenne Muscular Dystrophy.
- Answer
-
The National Institute for Health and Care Excellence (NICE) is evaluating Translarna (ataluren) for the treatment of Duchenne muscular dystrophy through its highly specialised technology programme. NICE currently expects to publish its final guidance in February 2016.
The National Health Service in England is legally required to fund drugs and treatments recommended in NICE highly specialised technology guidance within three months of its final guidance being issued. In the absence of guidance from NICE, it is for commissioners to make decisions on whether to fund medicines based on an assessment of the available evidence.
Secondary information
- Type
- Written question
- Reference
- 16534
- Session
- 2015-16
- Subjects
- Drugs Muscular dystrophy Ataluren
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2016-07-05 20:14:19 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2015-16/16534
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2015-16/16534
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2015-16/16534